<SEC-DOCUMENT>0001628280-23-039274.txt : 20231116
<SEC-HEADER>0001628280-23-039274.hdr.sgml : 20231116
<ACCEPTANCE-DATETIME>20231116125032
ACCESSION NUMBER:		0001628280-23-039274
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20231116
FILED AS OF DATE:		20231116
DATE AS OF CHANGE:		20231116

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CYBIN INC.
		CENTRAL INDEX KEY:			0001833141
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40673
		FILM NUMBER:		231413661

	BUSINESS ADDRESS:	
		STREET 1:		100 KING STREET WEST
		STREET 2:		SUITE 5600
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1C9
		BUSINESS PHONE:		(908) 764-8385

	MAIL ADDRESS:	
		STREET 1:		100 KING STREET WEST
		STREET 2:		SUITE 5600
		CITY:			TORONTO
		STATE:			A6
		ZIP:			M5X 1C9
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>cybininc-form6xk11x16x2023.htm
<DESCRIPTION>6-K
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i64ecbe071dce4a16a7ccd3884decc461_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="-sec-extract:summary;margin-bottom:5pt;margin-top:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">UNITED STATES<br>SECURITIES AND EXCHANGE COMMISSION</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Washington, D.C. 20549</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Form 6-K</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16<br>UNDER THE SECURITIES EXCHANGE ACT OF 1934</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font></div><div style="margin-bottom:5pt;margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">For the month of November, 2023.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Commission File Number&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">001-40673</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%;text-decoration:underline">Cybin Inc.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%"><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Exact Name of Registrant as Specified in Charter)<br><br></font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9 </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Address of principal executive offices) </font></div><div style="text-align:center"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Form 20-F  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:400;line-height:115%">&#9633;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">  Form 40-F &#8864;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">SIGNATURE</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.<br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.038%"><tr><td style="width:1.0%"></td><td style="width:5.048%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.398%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.696%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.851%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.507%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">CYBIN INC.</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">(Registrant)</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">&#160;</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">November 16, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">&#47;s&#47; Doug Drysdale&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Name&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Doug Drysdale</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Title&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:5pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%;text-decoration:underline">EXHIBIT INDEX</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.820%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">99.1</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline"><a href="a11-16x2023rdeventcurtainr.htm" style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%;text-decoration:underline">News Release dated November 16, 2023</a></font></div></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>a11-16x2023rdeventcurtainr.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i885dc6b6897d41fe8c3414b81e5cef33_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><img alt="image_0.jpg" src="image_0.jpg" style="height:120px;margin-bottom:5pt;vertical-align:text-bottom;width:206px"></div><div style="text-align:center"><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:133%"> Cybin to Release Phase 2 Topline Safety and Efficacy Data for CYB003 in Major Depressive Disorder and Host R&#38;D Briefing on November 30, 2023</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:133%">- Company to share topline Phase 2 safety and efficacy data for CYB003, its deuterated psilocybin analog being developed for the treatment of major depressive disorder -</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:133%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">TORONTO, CANADA </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8211; November 16, 2023 &#8211; </font><font style="color:#0563c1;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Cybin Inc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> (NYSE American&#58;CYBN) (NEO&#58;CYBN) (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Cybin</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221; or the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">&#8221;), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next generation psychedelic-based treatment options, today announced that it will host an R&#38;D briefing on Thursday, November 30, 2023, in New York City, at 10&#58;00am ET.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Institutional investors, analysts and company guests are cordially asked to save the date for this important upcoming session, which will feature an overview of the Company&#8217;s recently completed Phase 1&#47;2 trial of CYB003, and a detailed review of the topline safety and efficacy data. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Featured speakers will include members of Cybin&#8217;s leadership and scientific teams along with key neuroscience opinion leaders. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">A live webcast of the event will be available on the Company&#8217;s investor relations website on the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">Events &#38; Presentations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> page.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">About Cybin</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cybin is a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cybin&#8217;s goal of revolutionizing mental healthcare is supported by a network of world-class partners and internationally recognized scientists aimed at progressing proprietary drug discovery platforms, innovative drug delivery systems, and novel formulation approaches and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">treatment regimens. The Company is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, the United Kingdom, the Netherlands and Ireland.  For company updates and to learn more about Cybin, visit www.cybin.com or follow the team on X, LinkedIn, YouTube and Instagram.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:100%"></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:133%">Investor &#38; Media Contact&#58;&#160;</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Gabriel Fahel</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Chief Legal Officer</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">Cybin Inc.</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%">1-866-292-4601</font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">irteam&#64;cybin.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> &#8211; or &#8211; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%;text-decoration:underline">media&#64;cybin.com</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:400;line-height:133%"> </font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="padding-left:0.05pt;padding-right:5.75pt;text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_0.jpg
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MJ=FF'[^6 4Y!$M6S2.(*F2Q!IG<O0LZP'1[XVJ;Y:!_]N Y+EB8G;$K6CTV
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M@$. SIYBF_S;$.BG'/-K9'G$F$)HAH1Y$W!L[$%4<1[R 72_<MRAR!.KMN[
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M*LZ\ MP # LU* <]D%W@.P%KT9HPOP+^A_Q91B %,V(ET$T58]WD^/Y%D48
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M+V&Z]AY+P_>1 *-G8\+OFGT!22ZA6T[UPV&30 TSD%)R6C>EPY7B0+JEF G
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HR)) 9V &\ QP'C QVNB,,::*_P,XN9"3FUCC]     !)14Y$KD)@@@$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
